MiR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer

Molecular and Cellular Biochemistry

Volumn 386, Issue 1-2, 2014, Pages 223-231

  Tan, Zhiqin ^a,c   Jiang, Hao ^a   Wu, Youhua ^a   Xie, Liming ^a   Dai, Wenxiang ^a   Tang, Hailin ^a,b   Tang, Sanyuan ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c The 169th Hospital of PLA   (China)

Author keywords

Gastric cancer; miR 185; Prognostic significance

Indexed keywords

MICRORNA; MICRORNA 185; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DOWN REGULATION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; STOMACH CANCER; UPREGULATION;

ADULT; AGED; ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; FEMALE; HETEROGRAFTS; HUMANS; IN SITU HYBRIDIZATION; MALE; MICE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84891555541     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1860-y     Document Type: Article

References (31)

1. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009) Gastric cancer. Lancet 374:477-490. doi: 10.1016/S0140-6736(09)60617-6
2. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150. doi: 10.1200/JCO.2005.05.2308
3. Schickel R, Boyerinas B, Park SM, Peter ME (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27:5959-5974. doi: 10.1038/onc.2008.274
4. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136:586-591. doi: 10.1016/j.cell.2009.02.005
5. Slack FJ, Weidhaas JB (2008) MicroRNA in cancer prognosis. N Engl J Med 359:2720-2722. doi: 10.1056/NEJMe0808667
6. Hurst DR, Edmonds MD, Welch DR (2009) Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69:7495-7498. doi: 10.1158/0008-5472.CAN-09-2111
7. Bartels CL, Tsongalis GJ (2009) MicroRNAs: novel biomarkers for human cancer. Clin Chem 55:623-631. doi: 10.1373/clinchem.2008.112805
8. Akcakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H, Lui WO (2011) miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 39:311-318. doi: 10.3892/ijo.2011.1043
9. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F (2011) miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 301:151-160. doi: 10.1016/j.canlet.2010.11.009
10. Zhi Q, Zhu J, Guo X, He S, Xue X, Zhou J, Hu B, Li H, Chen S, Zhao H, Kuang Y (2013) Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Biomed Pharmacother 67:393-398. doi: 10.1016/j.biopha.2013.03.022
11. Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, Zhao R, Huang H, Wang X, Qiao Y, Li F, Han D, Wang L, Zhang G, Gao X (2013) MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene. doi: 10.1038/onc.2012.575
12. Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, Chen Y, Rao MK (2010) MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 29:4971-4979. doi: 10.1038/onc.2010.233
13. Qu F, Cui X, Hong Y, Wang J, Li Y, Chen L, Liu Y, Gao Y, Xu D, Wang Q (2013) MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol Cell Biochem 377:121-130. doi: 10.1007/s11010-013-1576-z
14. Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G (2011) MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol Cancer 10:124. doi: 10.1186/1476-4598-10-124
15. Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G, Wu M (2012) LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway. Curr Cancer Drug Targets 12:1032-1042
16. Tang H, Bian Y, Tu C, Wang Z, Yu Z, Liu Q, Xu G, Wu M, Li G (2013) The miR-183/96/182 cluster regulates oxidative apoptosis and sensitizes cells to chemotherapy in gliomas. Curr Cancer Drug Targets 13:221-231
17. Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang H, Zhou Y, Xiong W, Zhou M, Li X, Yan Q, Ma J, Li G (2013) miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumour Biol 34:1793-1800. doi: 10.1007/s13277-013-0718-y
18. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D (2010) Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59:579-585. doi: 10.1136/gut.2008.175497
19. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11:136-146. doi: 10.1016/S1470-2045(09)70343-2
20. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6:e1000879. doi: 10.1371/journal.pgen.1000879
21. Coburn NG (2009) Lymph nodes and gastric cancer. J Surg Oncol 99:199-206. doi: 10.1002/jso.21224
22. Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, Liu L, Jia D, Tian Q, Wu J, Ye Y, Wang Q, Long Z, Zhou Y, Du C, He X, Shi Y (2011) MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17:7574-7583. doi: 10.1158/1078-0432.CCR-11-1714
23. Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, Palanisamy N, Voorhoeve PM, Tan P (2011) Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17:2657-2667. doi: 10.1158/1078-0432.CCR-10-3152
24. Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M (2011) MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res 17:2725-2733. doi: 10.1158/1078-0432.CCR-10-2132
25. Lo SS, Hung PS, Chen JH, Tu HF, Fang WL, Chen CY, Chen WT, Gong NR, Wu CW (2012) Overexpression of miR-370 and downregulation of its novel target TGFbeta-RII contribute to the progression of gastric carcinoma. Oncogene 31:226-237. doi: 10.1038/onc.2011.226
26. Kogo R, Mimori K, Tanaka F, Komune S, Mori M (2011) Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 17:4277-4284. doi: 10.1158/1078-0432.CCR-10-2866
27. Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y, Wang X, Zhao Q, Ding J, Wu K, Fan D (2011) MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 15:1887-1895. doi: 10.1111/j.1582-4934.2010.01194.x
28. Sun T, Wang C, Xing J, Wu D (2011) miR-429 modulates the expression of c-myc in human gastric carcinoma cells. Eur J Cancer 47:2552-2559. doi: 10.1016/j.ejca.2011.05.021
29. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO, Yasuda J (2009) MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS ONE 4:e6677. doi: 10.1371/journal.pone.0006677
30. Liao JM, Lu H (2011) Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem 286:33901-33909. doi: 10.1074/jbc.M111.262030
31. Tang H, Deng M, Tang Y, Xie X, Guo J, Kong Y, Ye F, Su Q, Xie X (2013) miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res. doi: 10.1158/1078-0432.CCR-13-1326